ICD-9-CM Coordination and Maintenance (C&M) Committee Meeting, 8877-8878 [2012-3484]
Download as PDF
8877
Federal Register / Vol. 77, No. 31 / Wednesday, February 15, 2012 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Average
burden per
respondent
(in hours)
Respondent
Citation
Importer .............................................
20
1
15/60
5
5
40
1
1
30/60
10/60
3
7
30
5
20
4
1
1
30/60
1
1
60
5
20
Importer .............................................
71.51(b)(3) Dogs/cats: Record of
sickness or deaths.
71.52(d) Turtle Importation Permits
71.53(d) Importer Registration—
Nonhuman Primates.
71.53(e) Recordkeeping ...................
71.55 Dead bodies ...........................
71.56 (a)(2) African Rodents—Request for exemption.
71.56(a)(iii) Appeal ...........................
2
1
1
2
Total ...........................................
...........................................................
2,740,638
........................
........................
227,330
Importer .............................................
Non-Human Primate Importer ...........
Non-Human Primate Importer ...........
Importers ...........................................
Importer .............................................
Kimberly S. Lane,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2012–2951 Filed 2–14–12; 8:45 am]
BILLING CODE 4163–18–P
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2012–3487 Filed 2–14–12; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP STAC or Advisory
Committee), National Institute for
Occupational Safety and Health
(NIOSH)
sroberts on DSK5SPTVN1PROD with NOTICES
Correction
This notice was published in the
Federal Register on January 31, 2012,
Volume 77, Number 20, pages 4820–
4821. The meeting times and public
comment times should read as follows:
Committee Public Meeting Times and
Dates: (All times are Eastern Standard
Time).
12 p.m.–5 p.m., February 15, 2012, and
8:30 a.m.–4:00 p.m., February 16, 2012.
Public Comment Times and Dates:
(All times are Eastern Standard Time.)
3:45 p.m.–4:45 p.m., on February 15,
2012, and
8:45 a.m.–10:45 a.m., on February 16,
2012.
Contact Person for More Information:
Paul J. Middendorf, Ph.D., Designated
Federal Officer, NIOSH, CDC, 4676
Columbia Parkway, Mail Stop R–45,
Cincinnati, Ohio 45226, Telephone: 1
(888) 982–4748; email: wtcstac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
VerDate Mar<15>2010
17:09 Feb 14, 2012
Jkt 226001
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis (ACET)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
8:30 a.m.–5:30 p.m., March 6, 2012.
8:30 a.m.–2:30 p.m., March 7, 2012.
Place: CDC, Corporate Square, Building 8,
1st Floor Conference Room, Atlanta, Georgia
30333, telephone: (404) 639–8317.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters to be Discussed: Agenda items
include the following topics: (1) Tuberculosis
issues in special populations; (2) United
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Total burden
States-Mexico border activities update; (3)
tuberculosis outbreaks in federal prisons
update; (4) ACET Workgroups Activities
Updates; and (5) other tuberculosis-related
issues. Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Centers for Disease
Control and Prevention, 1600 Clifton Road
NE., M/S E–07, Atlanta, Georgia 30333,
telephone: (404) 639–8317.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–3486 Filed 2–14–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ICD–9–CM Coordination and
Maintenance (C&M) Committee
Meeting
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff, announces
the following meeting.
Name: ICD–9–CM Coordination and
Maintenance (C&M) Committee meeting.
Time and Date: 9 a.m.–5:30 p.m.,
March 5, 2012.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore,
Maryland 21244.
Status: Open to the public, limited
only by the space available. The meeting
E:\FR\FM\15FEN1.SGM
15FEN1
8878
Federal Register / Vol. 77, No. 31 / Wednesday, February 15, 2012 / Notices
room accommodates approximately 240
people.
Security Considerations: Due to
increased security requirements CMS
has instituted stringent procedures for
entrance into the building by nongovernment employees. Attendees will
need to present valid government-issued
picture identification, and sign-in at the
security desk upon entering the
building. Attendees who wish to attend
the ICD–9–CM C&M meeting on March
5, 2012, must submit their name and
organization by February 27, 2012, for
inclusion on the visitor list. This visitor
list will be maintained at the front desk
of the CMS building and used by the
guards to admit visitors to the meeting.
Participants who attended previous
ICD–9–CM C&M meetings will no longer
be automatically added to the visitor
list. You must request inclusion of your
name prior to each meeting you attend.
Please register to attend the meeting
on-line at: https://www.cms.hhs.gov/
apps/events/.
Please contact Mady Hue (410–786–
4510 or Marilu.hue@cms.hhs.gov), for
questions about the registration process.
Purpose: The ICD–9–CM Coordination
and Maintenance Committee is a public
forum for the presentation of proposed
modifications to the International
Classification of Diseases, NinthRevision, Clinical Modification.
Matters to be Discussed: Tentative
agenda items include:
March 5, 2012
ICD–9–CM Procedure Topics:
Administration of Fidaxomicin
Placement of Modeling Catheter in
Endovascular Graft Procedure
Injection or Infusion of Glucarpidase
ICD–10 Updates:
ICD–10 MS–DRG Update
ICD–10 HAC Translation List
Impact of ICD–10 MS–DRGs
Implementation
ICD–10–CM Diagnosis Topics:
Atypical femoral fracture
Choking ‘‘game’’
Cognitive sequelae of cerebrovascular
disease
Family history of SIDS
sroberts on DSK5SPTVN1PROD with NOTICES
Addenda
Agenda items are subject to change as
priorities dictate.
Note: CMS and NCHS will no longer
provide paper copies of handouts for the
meeting. Electronic copies of all meeting
materials will be posted on the CMS and
NCHS Web sites prior to the meeting at
https://www.cms.hhs.gov/
ICD9ProviderDiagnosticCodes/03_
meetings.asp#TopOfPage and https://
www.cdc.gov/nchs/icd/icd9cm_
maintenance.htm.
VerDate Mar<15>2010
17:09 Feb 14, 2012
Jkt 226001
Contact Persons for Additional
Information: Donna Pickett, Medical
Systems Administrator, Classifications
and Public Health Data Standards Staff,
NCHS, 3311 Toledo Road, Room 2337,
Hyattsville, Maryland 20782, email
dfp4@cdc.gov, telephone 301–458–4434
(diagnosis); Mady Hue, Health
Insurance Specialist, Division of Acute
Care, CMS, 7500 Security Boulevard,
Baltimore, Maryland 21244, email
marilu.hue@cms.hhs.gov, telephone
410–786–4510 (procedures).
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–3484 Filed 2–14–12; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
Correction
This notice was published in the
Federal Register on February 1, 2012,
Volume 77, Number 21, Page 5026. The
matters to be discussed and times
should read as follows:
Matters To Be Discussed: The agenda
will include discussions on:
meningococcal vaccine, hepatitis B
vaccine, tetanus, diphtheria, and
acellular pertussis (Tdap) vaccine,
influenza, vaccine supply, 13-valent
pneumococcal conjugate vaccine, and
measles-mumps-rubella (MMR) vaccine.
Recommendation vote is scheduled for
Tdap vaccine. Time will be available for
public comment.
Agenda items are subject to change as
priorities dictate.
Times and Dates:
8 a.m.–5 p.m., February 22, 2012.
8 a.m.–12:30 p.m., February 23, 2012.
The Meeting is Web cast live via the
World Wide Web; for instructions and
more information on ACIP please visit
the ACIP Web site: https://www.cdc.gov/
vaccines/recs/acip/.
Contact Person for More Information:
Stephanie B. Thomas, National Center
Frm 00078
Fmt 4703
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–3481 Filed 2–14–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
for Immunization and Respiratory
Diseases, CDC, 1600 Clifton Road NE.,
MS–A27, Atlanta, Georgia 30333,
telephone: (404)639–8836; Email
ACIP@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sfmt 4703
Title: Tracking of Participants in the
Head Start Impact Study.
OMB No.: 0970–0229.
Description: The Administration for
Children and Families (ACF) within the
Department of Health and Human
Services (HHS) will collect follow-up
information from children and families
in the Head Start Impact Study. In
anticipation of conducting a future
follow-up for the study, ACF will collect
information necessary to identify
respondents’ current location and
follow-up with respondents in the
future.
The Head Start Impact Study is a
longitudinal study involving 4,667 first
time enrolled three- and four-year-old
preschool children across 84 nationally
representative grantee/delegate
agencies. Participants have been
randomly assigned to either a Head Start
group or a control group. Data collection
for the study began in fall of 2002 and
has been extended through late spring
2008 to include the participants’ 3rd
grade year. Tracking of the participants
has continued every spring beginning in
2009 and ending in 2011.
ACF will continue to examine
outcomes for the sample through the
spring of the participant’s 12th grade
year. To maintain adequate sample size,
telephone interviews will be conducted
in order to update the respondent’s
location and contact information. This
information will be collected from
E:\FR\FM\15FEN1.SGM
15FEN1
Agencies
[Federal Register Volume 77, Number 31 (Wednesday, February 15, 2012)]
[Notices]
[Pages 8877-8878]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3484]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
ICD-9-CM Coordination and Maintenance (C&M) Committee Meeting
National Center for Health Statistics (NCHS), Classifications and
Public Health Data Standards Staff, announces the following meeting.
Name: ICD-9-CM Coordination and Maintenance (C&M) Committee
meeting.
Time and Date: 9 a.m.-5:30 p.m., March 5, 2012.
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore, Maryland 21244.
Status: Open to the public, limited only by the space available.
The meeting
[[Page 8878]]
room accommodates approximately 240 people.
Security Considerations: Due to increased security requirements CMS
has instituted stringent procedures for entrance into the building by
non-government employees. Attendees will need to present valid
government-issued picture identification, and sign-in at the security
desk upon entering the building. Attendees who wish to attend the ICD-
9-CM C&M meeting on March 5, 2012, must submit their name and
organization by February 27, 2012, for inclusion on the visitor list.
This visitor list will be maintained at the front desk of the CMS
building and used by the guards to admit visitors to the meeting.
Participants who attended previous ICD-9-CM C&M meetings will no
longer be automatically added to the visitor list. You must request
inclusion of your name prior to each meeting you attend.
Please register to attend the meeting on-line at: https://www.cms.hhs.gov/apps/events/.
Please contact Mady Hue (410-786-4510 or Marilu.hue@cms.hhs.gov),
for questions about the registration process.
Purpose: The ICD-9-CM Coordination and Maintenance Committee is a
public forum for the presentation of proposed modifications to the
International Classification of Diseases, Ninth-Revision, Clinical
Modification.
Matters to be Discussed: Tentative agenda items include:
March 5, 2012
ICD-9-CM Procedure Topics:
Administration of Fidaxomicin
Placement of Modeling Catheter in Endovascular Graft Procedure
Injection or Infusion of Glucarpidase
ICD-10 Updates:
ICD-10 MS-DRG Update
ICD-10 HAC Translation List
Impact of ICD-10 MS-DRGs Implementation
ICD-10-CM Diagnosis Topics:
Atypical femoral fracture
Choking ``game''
Cognitive sequelae of cerebrovascular disease
Family history of SIDS
Addenda
Agenda items are subject to change as priorities dictate.
Note: CMS and NCHS will no longer provide paper copies of
handouts for the meeting. Electronic copies of all meeting materials
will be posted on the CMS and NCHS Web sites prior to the meeting at
https://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and https://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm.
Contact Persons for Additional Information: Donna Pickett, Medical
Systems Administrator, Classifications and Public Health Data Standards
Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782,
email dfp4@cdc.gov, telephone 301-458-4434 (diagnosis); Mady Hue,
Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security
Boulevard, Baltimore, Maryland 21244, email marilu.hue@cms.hhs.gov,
telephone 410-786-4510 (procedures).
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-3484 Filed 2-14-12; 8:45 am]
BILLING CODE 4163-18-P